HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Burt, M. Articles by Rusch, V. W. Search for Related Content PubMed PubMed Citation Articles by Burt, M. Articles by Rusch, V. W.

The Annals of Thoracic Surgery, Vol 52, 1222-1228, Copyright © 1991 by The Society of Thoracic Surgeons

ARTICLES

Malignant esophagorespiratory fistula: management options and survival

M Burt, W Diehl, N Martini, MS Bains, RJ Ginsberg, PM McCormack and VW Rusch
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

The development of a malignant esophagorespiratory fistula is a devastating complication. Data comparing various treatment options in a large group of patients are sparse. To assess the results of therapy, we reviewed our experience in 207 patients with malignant esophagorespiratory fistula. Records of 207 patients admitted to our institution with malignant esophagorespiratory fistula from 1926 to 1988 were reviewed and results of management analyzed. Age ranged from 21 to 90 years (median, 59 years); the male/female ratio was 3:1. Primary tumor site was esophagus in 161 (77%), lung in 33 (16%), trachea in 5 (2%), metastatic nodes in 4 (2%), larynx in 3 (1%), and thyroid in 1. Symptoms and signs of malignant esophagorespiratory fistula included cough in 116 (56%), aspiration in 77 (37%), fever in 52 (25%), dysphagia in 39 (19%), pneumonia in 11 (5%), hemoptysis in 10 (5%), and chest pain in 10 (5%). Respiratory location of fistula included trachea in 110 (53%), left main bronchus in 46 (22%), right bronchus in 33 (16%), lung parenchyma in 13 (6%), and multiple sites in 5 (2%). The percentage of patients alive at 3, 6, and 12 months by treatment modality was 13%, 4%, and 1% for supportive care (n = 104); 17%, 3%, and 0% for esophageal exclusion (n = 29); 21%, 14%, and 0% for esophageal intubation (n = 14); 30%, 15%, and 5% for radiation therapy (n = 20); and 46%, 20%, and 7% for esophageal bypass, respectively. Patients treated with radiation therapy and esophageal bypass had a significantly prolonged survival compared with patients treated with the other modalities.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				J. H. Shin, H.-Y. Song, G.-Y. Ko, J.-O. Lim, H.-K. Yoon, and K.-B. Sung Esophagorespiratory Fistula: Long-term Results of Palliative Treatment with Covered Expandable Metallic Stents in 61 Patients Radiology, July 1, 2004; 232(1): 252 - 259. [Abstract] [Full Text] [PDF]

				P. C. Enzinger and R. J. Mayer Esophageal Cancer N. Engl. J. Med., December 4, 2003; 349(23): 2241 - 2252. [Full Text] [PDF]

				B. P. Whooley, S. Law, S. C. Murthy, A. Alexandrou, K.-M. Chu, and J. Wong The Kirschner Operation in Unresectable Esophageal Cancer: Current Application Arch Surg, November 1, 2002; 137(11): 1228 - 1232. [Abstract] [Full Text] [PDF]

				T. Franquet, J. J. Erasmus, A. Gimenez, S. Rossi, and R. Prats The Retrotracheal Space: Normal Anatomic and Pathologic Appearances RadioGraphics, October 1, 2002; 22(90001): S231 - 246. [Abstract] [Full Text] [PDF]

				A case of cough and dysphagia Postgrad. Med. J., February 1, 2002; 78(916): 111 - 111. [Full Text] [PDF]

				E. P. Alexander, G. D. Trachiotis, T. O. Lipman, and R. G. Wadleigh Evolving management and outcome of esophageal cancer with airway involvement Ann. Thorac. Surg., May 1, 2001; 71(5): 1640 - 1644. [Abstract] [Full Text] [PDF]

				J. V. Dam and W. R. Brugge Endoscopy of the Upper Gastrointestinal Tract N. Engl. J. Med., December 2, 1999; 341(23): 1738 - 1748. [Full Text] [PDF]

				J. Jougon and L. Couraud Esophageal patching for an unsuturable tracheoesophageal fistula Eur. J. Cardiothorac. Surg., October 1, 1999; 14(4): 431 - 433. [Abstract] [Full Text] [PDF]

				E. S. Kassis, C. P. Belani, P. F. Ferson, R. J. Keenan, and J. D. Luketich Hodgkin's disease presenting with a bronchoesophageal fistula Ann. Thorac. Surg., October 1, 1998; 66(4): 1409 - 1410. [Abstract] [Full Text] [PDF]

				D. E. Low and R. A. Kozarek Comparison of Conventional and Wire Mesh Expandable Prostheses and Surgical Bypass in Patients With Malignant Esophagorespiratory Fistulas Ann. Thorac. Surg., April 1, 1998; 65(4): 919 - 923. [Abstract] [Full Text] [PDF]

				B. Meunier, C. Stasik, J.-L. Raoul, Y. Spiliopoulos, M. Lakehal, J.-P. Campion, and B. Launois Gastric bypass for malignant esophagotracheal fistula: A series of 21 cases Eur. J. Cardiothorac. Surg., February 1, 1998; 13(2): 184 - 189. [Abstract] [Full Text] [PDF]

				G. D. Trachiotis and W. R. Hix Repair of Tracheogastric Fistula After Cervical Exenteration Ann. Thorac. Surg., February 1, 1996; 61(2): 719 - 721. [Abstract] [Full Text]

				K. Wong and P. Goldstraw Role of Covered Esophageal Stents in Malignant Esophagorespiratory Fistula Ann. Thorac. Surg., July 1, 1995; 60(1): 199 - 200. [Abstract] [Full Text]